Sri Lanka

in page functions
Total population (2012)21,223,550
Birth cohort (2012)367,154
Surviving Infants (surviving to 1 year per year, 2012)363,038
Infant mortality rate (deaths < 1 year per 1000 births, 2012)11.21/1000
Child mortality rate (deaths < 5 years per 1000 births, 2012)13.08/1000
World Bank Index, IDA (2012)3.53
Gross Nation Income (per capita US$, 2010)2,240
Co-financing status (2012)Graduating
No. of districts/territories (2009)26

Contact GAVI

For more info, contact GAVI country representative officer or email here

GAVI support for Sri Lanka

Type of support

Approvals

2001-2016 (US$)
(31 Dec 2011)

Commitments

2001-2016 (US$)
(31 Dec 2011)

Disbursements

2001-2012 (US$)
(31 Dec 2011)

% Disbursed

(31 Dec 2011)
20022003200420052006200720082009201020112012201320142015
Health System Strengthening (HSS)$3,630,000$4,505,000$3,447,77095%
HepB mono (NVS)$2,486,882$2,486,882$2,486,882100%
Injection Safety Support (INS)$709,749$709,749$709,749100%
Penta (NVS)$15,112,787$18,563,787$15,927,088105%
Vaccine Introduction Grant$200,000$200,000$200,000100%
Total$22,139,418$26,465,418$22,771,490

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the GAVI Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding (IRC Reviewed)

Download data for commitments & disbursements in XLS format

Sri Lanka DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2010)99%
DTP3 - Official country estimates (2010)99%
M:F sex ratio at birth (2012)1.04%
Household survey: DTP3 coverage for male (1987)89.70%
Household survey: DTP3 coverage for female (1987)91.40%
Household survey: Last DTP3 survey (1987)91%
% districts achieving > 80% DTP3 coverage (2010)58%
% districts achieving < 50% DTP3 coverage (2010)0%
MCV WHO/UNICEF estimates (2010)99%
Polio WHO/UNICEF estimates (2010)99%

Breakdown of support

CSO, HSS & ISS supportVaccine support
19% 81%
$4,357,519 $18,413,970

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Sri Lanka

15 January 2009

Bangladesh introduces new vaccine to prevent severe forms of child pneumonia and meningitis

Today, Bangladesh introduces a new combination vaccine that will protect its children against five killer diseases in one injection, including, for the first time, the deadly bacterium Haemophilus influenzae type b (Hib) that causes some severe forms of pneumonia and meningitis.

01 July 2007

Popular appeal in Sri Lanka

Sri Lanka has one of the highest immunisation rates in South Asia because the people have welcomed and supported the government's vaccination programmes which the GAVI Alliance has funded.

28 June 2007

Hib vaccine - critical in Asia's effort to reduce child deaths

A new study from Bangladesh published online today in The Pediatric Infectious Disease Journal shows that routinely vaccinating infants against H. influenzae type b (Hib), a bacterium that causes deadly Hib pneumonia and meningitis, could save hundreds of thousands of children in Asia. Results showed that routine immunization of infants with a Hib conjugate vaccine prevented over one-third of life-threatening pneumonia cases and approximately 90% of Hib meningitis cases. A similar impact would be expected in other parts of the region.

close icon

modal window here